These data demonstrate that ATGL upregulation in the liver due to decreased ROS levels as a result of impaired peroxisomal β-oxidation or through pharmacological intervention by NAC promotes mobilization of TAG stores, thus preventing lipid build-up and progression of steatosis (Fig. 7k). The gene discussed is PNPLA2; the disease is steatosis.